ZNF664

Summary

ZNF664 (zinc finger protein 664, HGNC:25406) is a protein-coding gene on chromosome 12q24.31, encoding Zinc finger protein 664 (Q8N3J9). May be involved in transcriptional regulation.

Predicted to enable DNA-binding transcription factor activity, RNA polymerase II-specific and RNA polymerase II cis-regulatory region sequence-specific DNA binding activity. Predicted to be involved in regulation of DNA-templated transcription. Located in nucleus.

Source: NCBI Gene 144348 — RefSeq curated summary.

At a glance

• GWAS associations: 67
• Clinical variants (ClinVar): 18 total
• MANE Select transcript: NM_152437

Identifiers

Gene identifiers

Field	Value
HGNC ID	HGNC:25406
Approved symbol	ZNF664
Name	zinc finger protein 664
Location	12q24.31
Locus type	gene with protein product
Status	Approved
Aliases	ZFOC1, DKFZp761B128
Ensembl gene	ENSG00000179195
Ensembl biotype	protein_coding
OMIM	617890
Entrez	144348

Gene structure

Transcript identifiers

Ensembl transcripts: 60 — 50 protein_coding, 8 protein_coding_CDS_not_defined, 2 retained_intron

ENST00000337815, ENST00000392404, ENST00000537532, ENST00000538932, ENST00000539257, ENST00000539501, ENST00000539644, ENST00000540009, ENST00000540498, ENST00000541448, ENST00000542493, ENST00000542820, ENST00000543017, ENST00000546098, ENST00000901659, ENST00000901660, ENST00000901661, ENST00000901662, ENST00000901663, ENST00000901664, ENST00000901665, ENST00000901666, ENST00000901667, ENST00000901668, ENST00000901669, ENST00000901670, ENST00000901671, ENST00000901672, ENST00000901673, ENST00000901674, ENST00000901675, ENST00000901676, ENST00000901677, ENST00000901678, ENST00000901679, ENST00000901680, ENST00000901681, ENST00000901682, ENST00000901683, ENST00000901684, ENST00000901685, ENST00000901686, ENST00000901687, ENST00000901688, ENST00000901689, ENST00000901690, ENST00000901691, ENST00000901692, ENST00000901693, ENST00000901694, ENST00000901695, ENST00000901696, ENST00000901697, ENST00000915687, ENST00000915688, ENST00000915689, ENST00000915690, ENST00000963055, ENST00000963056, ENST00000963057

RefSeq mRNA: 2 — MANE Select: NM_152437 NM_001204298, NM_152437

CCDS: CCDS9257

Canonical transcript exons

ENST00000337815 — 5 exons

Exon	Start	End
ENSE00001285710	124011381	124011441
ENSE00001285732	123988043	123988138
ENSE00002318983	123973215	123973352
ENSE00003624130	123973886	123974020
ENSE00003841583	124011546	124015427

Expression profiles

Bgee: expression breadth ubiquitous, 255 present calls, max score 99.39.

FANTOM5 (CAGE): breadth ubiquitous, TPM avg 44.1554 / max 333.6317, expressed in 1813 samples.

FANTOM5 promoters (3 alternative TSS)

Promoter ID	TPM avg	Samples expressed
128613	44.1554	1813
128612	1.1151	694
128615	0.2904	93

Top tissues by expression

256 total, by Bgee expression score (0-100, higher = more expressed):

Tissue	Anatomy ID	Expression score	Quality
ileal mucosa	UBERON:0000331	99.39	gold quality
secondary oocyte	CL:0000655	99.14	gold quality
bronchial epithelial cell	CL:0002328	98.90	gold quality
kidney epithelium	UBERON:0004819	98.86	gold quality
left ventricle myocardium	UBERON:0006566	98.82	gold quality
jejunal mucosa	UBERON:0000399	98.78	gold quality
cardiac muscle of right atrium	UBERON:0003379	98.78	gold quality
bronchus	UBERON:0002185	98.77	gold quality
germinal epithelium of ovary	UBERON:0001304	98.27	gold quality
corpus epididymis	UBERON:0004359	98.25	gold quality
lateral globus pallidus	UBERON:0002476	98.24	gold quality
mucosa of paranasal sinus	UBERON:0005030	98.23	gold quality
pigmented layer of retina	UBERON:0001782	98.19	gold quality
epithelium of nasopharynx	UBERON:0001951	98.17	gold quality
subthalamic nucleus	UBERON:0001906	98.15	gold quality
globus pallidus	UBERON:0001875	98.08	gold quality
mucosa of sigmoid colon	UBERON:0004993	98.08	gold quality
palpebral conjunctiva	UBERON:0001812	98.07	gold quality
caput epididymis	UBERON:0004358	98.07	gold quality
C1 segment of cervical spinal cord	UBERON:0006469	98.05	gold quality
medial globus pallidus	UBERON:0002477	98.04	gold quality
parotid gland	UBERON:0001831	98.01	gold quality
inferior vagus X ganglion	UBERON:0005363	97.98	gold quality
postcentral gyrus	UBERON:0002581	97.91	gold quality
spinal cord	UBERON:0002240	97.89	gold quality
visceral pleura	UBERON:0002401	97.88	gold quality
parietal pleura	UBERON:0002400	97.85	gold quality
duodenum	UBERON:0002114	97.84	gold quality
ganglionic eminence	UBERON:0004023	97.81	gold quality
colonic mucosa	UBERON:0000317	97.76	gold quality

Single-cell (SCXA)

Detected in 2 experiment(s), a significant marker in 1.

Experiment	Marker?	Max mean expression
E-ANND-3	yes	15.74
E-MTAB-6678	no	3.33

Regulation

Is transcription factor: no

miRNA regulators (miRDB)

85 targeting ZNF664, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):

miRNA	Max score	Avg score	miRNA target_count
HSA-MIR-4476	100.00	68.18	2030
HSA-MIR-6876-5P	100.00	67.68	2126
HSA-MIR-3134	100.00	66.43	777
HSA-MIR-4668-3P	100.00	68.74	2635
HSA-MIR-340-5P	100.00	72.50	4437
HSA-MIR-12118	100.00	65.88	1270
HSA-MIR-4262	100.00	73.26	3931
HSA-MIR-3120-5P	100.00	65.56	965
HSA-MIR-3667-3P	99.99	67.17	1636
HSA-MIR-4534	99.99	66.58	1907
HSA-MIR-3662	99.99	73.82	5684
HSA-MIR-181A-5P	99.99	72.96	2995
HSA-MIR-181B-5P	99.99	72.97	2996
HSA-MIR-181C-5P	99.99	72.95	2996
HSA-MIR-181D-5P	99.99	73.04	2997
HSA-MIR-548P	99.98	72.25	3784
HSA-MIR-3173-3P	99.98	66.49	1217
HSA-MIR-6891-5P	99.98	66.53	1372
HSA-MIR-3688-3P	99.97	72.02	2834
HSA-MIR-607	99.97	73.62	5593
HSA-MIR-9-3P	99.96	70.88	2068
HSA-MIR-495-3P	99.96	72.81	4197
HSA-MIR-5688	99.96	73.23	4504
HSA-MIR-551B-5P	99.96	71.28	3493
HSA-MIR-4760-3P	99.93	70.50	2385
HSA-MIR-3119	99.92	71.34	2390
HSA-MIR-1297	99.91	73.41	3162
HSA-MIR-3671	99.90	73.04	3897
HSA-MIR-182-5P	99.87	74.03	2589
HSA-MIR-4503	99.85	71.45	1869

Cross-species orthologs

4 orthologs

Organism	Symbol	Gene ID
mus_musculus	Zfp664	ENSMUSG00000079215
rattus_norvegicus	Zfp664	ENSRNOG00000064009
drosophila_melanogaster	CG18476	FBGN0037931
drosophila_melanogaster	CG10669	FBGN0039329

Paralogs (5): ZNF648 (ENSG00000179930), ZNF721 (ENSG00000182903), ZFP62 (ENSG00000196670), ZNF485 (ENSG00000198298), ZNF808 (ENSG00000198482)

Protein

Protein identifiers

Zinc finger protein 664 — Q8N3J9 (reviewed: Q8N3J9)

Alternative names: Zinc finger protein 176, Zinc finger protein from organ of Corti

All UniProt accessions (1): Q8N3J9

UniProt curated annotations — full annotation on UniProt →

Function. May be involved in transcriptional regulation.

Subcellular location. Nucleus.

Similarity. Belongs to the krueppel C2H2-type zinc-finger protein family.

RefSeq proteins (2): NP_001191227, NP_689650* (*=MANE)

Domains & families (InterPro)

ID	Name	Type
IPR013087	Znf_C2H2_type	Domain
IPR036236	Znf_C2H2_sf	Homologous_superfamily

Pfam: PF00096

UniProt features (16 total): zinc finger region 9, sequence conflict 5, chain 1, cross-link 1

Structure

Experimental structures (PDB)

0 structures.

Predicted structure (AlphaFold)

Model	pLDDT	Fraction very-high
AF-Q8N3J9-F1	91.40	0.77

Functional residue map

Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.

Post-translational modifications (1): 257

Function

Pathways and Gene Ontology

Reactome pathways

1 pathways

ID	Pathway
R-HSA-212436	Generic Transcription Pathway

MSigDB gene sets: 103 (showing top): AAGTCCA_MIR422B_MIR422A, CTAGGAA_MIR384, SOX9_B1, SCHAEFFER_PROSTATE_DEVELOPMENT_6HR_DN, SCHAEFFER_PROSTATE_DEVELOPMENT_AND_CANCER_BOX1_UP, SCHAEFFER_PROSTATE_DEVELOPMENT_AND_CANCER_BOX4_DN, TGGNNNNNNKCCAR_UNKNOWN, GRYDER_PAX3FOXO1_ENHANCERS_IN_TADS, GRYDER_PAX3FOXO1_TOP_ENHANCERS, TCCCRNNRTGC_UNKNOWN, chr12q24, GOMF_SEQUENCE_SPECIFIC_DNA_BINDING, GRYDER_PAX3FOXO1_ENHANCERS_KO_DOWN, ERR1_Q2, STK33_DN

GO Biological Process (2): regulation of DNA-templated transcription (GO:0006355), regulation of transcription by RNA polymerase II (GO:0006357)

GO Molecular Function (6): RNA polymerase II cis-regulatory region sequence-specific DNA binding (GO:0000978), DNA-binding transcription factor activity, RNA polymerase II-specific (GO:0000981), zinc ion binding (GO:0008270), DNA binding (GO:0003677), protein binding (GO:0005515), metal ion binding (GO:0046872)

GO Cellular Component (1): nucleus (GO:0005634)

Reactome top-level categories

Rollup of top-1 pathways:

Category	Pathways
RNA Polymerase II Transcription	1

GO top-level categories

Rollup of top GO terms by namespace:

Category	Terms
RNA polymerase II transcription regulatory region sequence-specific DNA binding	2
DNA-templated transcription	1
regulation of gene expression	1
regulation of RNA biosynthetic process	1
regulation of DNA-templated transcription	1
transcription by RNA polymerase II	1
cis-regulatory region sequence-specific DNA binding	1
chromatin	1
DNA-binding transcription factor activity	1
regulation of transcription by RNA polymerase II	1
transition metal ion binding	1
nucleic acid binding	1
binding	1
cation binding	1
intracellular membrane-bounded organelle	1

Protein interactions and networks

STRING

562 interactions, top by confidence (×1000):

Protein A	Protein B	Partner UniProt	Score
ZNF664	CCDC92	Q53HC0	797
ZNF664	DNAH10	Q8IVF4	702
ZNF664	RFLNA	Q6ZTI6	543
ZNF664	GALNT2	Q10471	448
ZNF664	NT5DC2	Q9H857	448
ZNF664	OR56B1	Q8NGI3	447
ZNF664	SORCS1	Q8WY21	446
ZNF664	CMIP	Q8IY22	442
ZNF664	C5orf67	F2Z3F1	431
ZNF664	COBLL1	Q53SF7	419
ZNF664	TRIB1	Q96RU8	418
ZNF664	ARL15	Q9NXU5	416
ZNF664	FOXN3	O00409	413
ZNF664	TEX19	Q8NA77	398
ZNF664	SECTM1	Q8WVN6	374

IntAct

34 interactions, top by confidence:

A	B	Type	Score
MPDZ	SMCHD1	psi-mi:“MI:0914”(association)	0.590
CIB3	ZNF664	psi-mi:“MI:0915”(physical association)	0.560
	ZNF664	psi-mi:“MI:0915”(physical association)	0.560
CABP5	ZNF664	psi-mi:“MI:0915”(physical association)	0.560
ZNF664	ZNF330	psi-mi:“MI:0915”(physical association)	0.560
ZNF664	CIB3	psi-mi:“MI:0915”(physical association)	0.560
ZNF664	CABP5	psi-mi:“MI:0915”(physical association)	0.560
GADD45G	ZNF664	psi-mi:“MI:0915”(physical association)	0.560
VWCE	ZNF316	psi-mi:“MI:0914”(association)	0.530
IGFBP1	SUSD5	psi-mi:“MI:0914”(association)	0.530
RETN	GLI4	psi-mi:“MI:0914”(association)	0.530
RGS20	PGP	psi-mi:“MI:0914”(association)	0.350
ZNF227	ZNF664	psi-mi:“MI:0914”(association)	0.350
NOTCH2	ZNF320	psi-mi:“MI:0914”(association)	0.350
LTBP2	ZNF320	psi-mi:“MI:0914”(association)	0.350
FBLN2	ZNF316	psi-mi:“MI:0914”(association)	0.350
ST14	LIPT2	psi-mi:“MI:0914”(association)	0.350
ZNF664	GAPDHS	psi-mi:“MI:0914”(association)	0.350
TRAK1	PEX14	psi-mi:“MI:0914”(association)	0.350
LY6H	NXPH4	psi-mi:“MI:0914”(association)	0.350
	NFIB	psi-mi:“MI:0914”(association)	0.350
ZNF330	ZNF664	psi-mi:“MI:0915”(physical association)	0.000
GADD45G	ZNF664	psi-mi:“MI:0915”(physical association)	0.000

BioGRID (32): ZNF664 (Affinity Capture-MS), ZNF664 (Affinity Capture-MS), ZNF664 (Affinity Capture-MS), ZNF664 (Affinity Capture-MS), ZNF664 (Affinity Capture-MS), ZNF664 (Affinity Capture-MS), ZNF664 (Two-hybrid), ZNF664 (Two-hybrid), ZNF664 (Two-hybrid), ZNF664 (Two-hybrid), KRTAP10-1 (Two-hybrid), ZNF664 (Affinity Capture-RNA), ZNF664 (Affinity Capture-MS), STRIP1 (Affinity Capture-MS), ZNF664 (Affinity Capture-MS)

ESM2 similar proteins: O73694, P18712, P18717, P18719, P18720, P18721, P18722, P18724, P18727, P18730, P18731, P18732, P18734, P18735, P18738, P18740, P18741, P18742, P18743, P18744, P18750, P24399, P26634, P26635, P31507, P31508, P31509, Q01779, Q01792, Q01793, Q01797, Q01799, Q01800, Q01871, Q01872, Q02025, Q02026, Q02027, Q02034, Q02035

Diamond homologs: Q4VA44, Q5RAM9, Q60493, Q8N3J9

SIGNOR signaling

0 interactions.

Disease & clinical

Clinical variants and AI predictions

ClinVar

18 variants total. Per-class counts are floors (≥ shown; pagination cap):

Classification	Count (floor)
Pathogenic	0
Likely pathogenic	0
Uncertain significance	17
Likely benign	1
Benign	0

Top pathogenic / likely-pathogenic (0)

SpliceAI

1338 predictions. Top by Δscore:

Variant	Effect	Δscore
12:123974018:CAGGT:C	donor_loss	1.0000
12:123974019:AGG:A	donor_loss	1.0000
12:123974020:GGT:G	donor_loss	1.0000
12:123976224:G:GT	donor_gain	1.0000
12:123973301:G:T	donor_gain	0.9900
12:123973350:GGA:G	donor_gain	0.9900
12:123973351:GAG:G	donor_gain	0.9900
12:123973353:G:GG	donor_gain	0.9900
12:123974018:CAGG:C	donor_loss	0.9900
12:123974021:GT:G	donor_loss	0.9900
12:123974021:GTA:G	donor_loss	0.9900
12:123974022:T:G	donor_loss	0.9900
12:123976203:T:G	donor_gain	0.9900
12:124011379:A:AG	acceptor_gain	0.9900
12:124011380:G:GG	acceptor_gain	0.9900
12:123973351:GA:G	donor_gain	0.9800
12:123976224:G:T	donor_gain	0.9800
12:123976239:G:T	donor_gain	0.9800
12:123989289:T:G	acceptor_gain	0.9800
12:124011437:AAAAG:A	donor_loss	0.9800
12:124011438:AAAG:A	donor_loss	0.9800
12:124011439:AAGG:A	donor_loss	0.9800
12:124011440:AG:A	donor_loss	0.9800
12:124011440:AGG:A	donor_loss	0.9800
12:124011441:G:GT	donor_loss	0.9800
12:124011441:GG:G	donor_loss	0.9800
12:124011442:G:T	donor_loss	0.9800
12:124011443:T:G	donor_loss	0.9800
12:123973399:G:GT	donor_gain	0.9700
12:123973400:G:T	donor_gain	0.9700

AlphaMissense

1787 scored. Top likely-pathogenic:

Variant	Protein change	am_pathogenicity
12:124012514:T:C	F124L	0.998
12:124012516:T:A	F124L	0.998
12:124012516:T:G	F124L	0.998
12:124012598:T:C	F152L	0.998
12:124012600:C:A	F152L	0.998
12:124012600:C:G	F152L	0.998
12:124012682:T:C	F180L	0.998
12:124012684:C:A	F180L	0.998
12:124012684:C:G	F180L	0.998
12:124012766:T:C	F208L	0.997
12:124012768:C:A	F208L	0.997
12:124012768:C:G	F208L	0.997
12:124012430:T:C	F96L	0.996
12:124012432:C:A	F96L	0.996
12:124012432:C:G	F96L	0.996
12:124012850:T:C	F236L	0.996
12:124012852:C:A	F236L	0.996
12:124012852:C:G	F236L	0.996
12:124012709:C:G	H189D	0.993
12:124012449:T:C	L102P	0.992
12:124012515:T:C	F124S	0.992
12:124012533:T:C	L130P	0.992
12:124012701:T:C	L186P	0.992
12:124012711:C:A	H189Q	0.992
12:124012711:C:G	H189Q	0.992
12:124012683:T:C	F180S	0.991
12:124012543:T:A	H133Q	0.990
12:124012543:T:G	H133Q	0.990
12:124012599:T:C	F152S	0.990
12:124012617:T:C	L158P	0.990

dbSNP variants (sampled 300 via entrez): RS1000005912 (12:123978645 C>G), RS1000106696 (12:123978301 T>C), RS1000145084 (12:124013947 A>C,G), RS1000227671 (12:123990088 A>G,T), RS1000317136 (12:123977860 A>G), RS1000351428 (12:123973221 TC>T,TCC), RS1000491757 (12:124007879 G>A), RS1000508148 (12:123982925 C>T), RS1000515484 (12:123989140 A>G), RS1000582197 (12:123990520 C>T), RS1000604963 (12:123995163 C>T), RS1000642259 (12:123988936 C>T), RS1000686141 (12:123982776 A>G), RS1000693148 (12:123989245 C>T), RS1000741109 (12:123982629 G>A)

Disease associations

OMIM: gene MIM:617890 | disease phenotypes:

GenCC curated gene-disease

Mondo (0):

Orphanet (0):

HPO phenotypes

0 total (0 of 0 shown, HPO-id order):

GWAS associations

67 associations (top):

Study	Trait	p-value
GCST000755_47	HDL cholesterol	3.000000e-10
GCST000758_20	Triglycerides	1.000000e-08
GCST001523_44	Visceral adipose tissue adjusted for BMI	9.000000e-06
GCST001524_26	Visceral adipose tissue/subcutaneous adipose tissue ratio	7.000000e-06
GCST002216_10	Triglycerides	2.000000e-08
GCST002223_66	HDL cholesterol	8.000000e-10
GCST002233_8	Adiponectin levels	2.000000e-07
GCST002399_1	Clubfoot	2.000000e-07
GCST002782_127	Waist-to-hip ratio adjusted for body mass index	7.000000e-15
GCST002782_128	Waist-to-hip ratio adjusted for body mass index	7.000000e-14
GCST002782_129	Waist-to-hip ratio adjusted for body mass index	6.000000e-14
GCST002782_130	Waist-to-hip ratio adjusted for body mass index	2.000000e-13
GCST004064_51	Waist-hip ratio	1.000000e-09
GCST004064_73	Waist-hip ratio	2.000000e-06
GCST004232_10	HDL cholesterol levels	1.000000e-34
GCST004234_12	HDL cholesterol levels	6.000000e-10
GCST004237_10	Triglyceride levels	2.000000e-11
GCST004505_3	Waist-to-hip ratio adjusted for BMI (adjusted for smoking behaviour)	3.000000e-08
GCST004505_4	Waist-to-hip ratio adjusted for BMI (adjusted for smoking behaviour)	3.000000e-09
GCST005956_10	Waist-to-hip ratio adjusted for BMI	6.000000e-08
GCST005958_11	Waist-to-hip ratio adjusted for BMI (age >50)	4.000000e-07
GCST005962_22	Waist-to-hip ratio adjusted for BMI x sex x age interaction (4df test)	1.000000e-08
GCST009107_2	Body mass index variance	1.000000e-10
GCST009380_5	Type 2 diabetes (adjusted for BMI)	2.000000e-08
GCST009380_6	Type 2 diabetes (adjusted for BMI)	2.000000e-06
GCST009404_21	Optic cup area	1.000000e-10
GCST009602_23	Metabolic syndrome	4.000000e-10
GCST009723_71	Vertical cup-disc ratio (adjusted for vertical disc diameter)	2.000000e-09
GCST009724_100	Vertical cup-disc ratio (multi-trait analysis)	2.000000e-14
GCST010002_177	Refractive error	4.000000e-08

EFO canonical traits (15, from GWAS)

EFO ID	Trait name
EFO:0004612	high density lipoprotein cholesterol measurement
EFO:0004530	triglyceride measurement
EFO:0004340	body mass index
EFO:0004767	visceral:subcutaneous adipose tissue ratio
EFO:0004502	adiponectin measurement
EFO:0007788	BMI-adjusted waist-hip ratio
EFO:0004343	waist-hip ratio
EFO:0004318	smoking behavior
EFO:0008007	age at assessment
EFO:0008343	sex interaction measurement
EFO:0000195	metabolic syndrome
EFO:0006939	cup-to-disc ratio measurement
EFO:0004995	lean body mass
EFO:0007789	BMI-adjusted waist circumference
EFO:0008039	BMI-adjusted hip circumference

Drugs & pharmacology

Drug and pharmacology data

Is drug target: no

PharmGKB: 1 entry (VIP=true, CPIC=false)

CTD chemical–gene interactions

26 total (human), top 26 by PubMed support.

Chemical	Actions (top 5)	PubMed papers
sodium arsenite	increases abundance, increases expression, decreases expression	3
entinostat	decreases expression, affects cotreatment	2
Valproic Acid	decreases expression, decreases methylation	2
Cyclosporine	increases expression, increases methylation	2
Cadmium Chloride	decreases expression, increases expression	2
aristolochic acid I	decreases expression	1
TAK-243	increases sumoylation	1
triphenyl phosphate	affects expression	1
cobaltous chloride	decreases expression	1
manganese chloride	increases abundance, increases expression	1
CGP 52608	affects binding, increases reaction	1
K 7174	increases expression	1
4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide	affects cotreatment, decreases expression	1
ICG 001	increases expression	1
dorsomorphin	affects cotreatment, decreases expression	1
4-(4-((5-(4,5-dimethyl-2-nitrophenyl)-2-furanyl)methylene)-4,5-dihydro-3-methyl-5-oxo-1H-pyrazol-1-yl)benzoic acid	increases expression	1
Sunitinib	increases expression	1
Arsenic	increases abundance, increases expression	1
Atrazine	decreases expression	1
Benzo(a)pyrene	decreases methylation	1
Diethylstilbestrol	decreases expression	1
Doxorubicin	decreases expression	1
Manganese	increases abundance, increases expression	1
Tretinoin	decreases expression	1
Triiodothyronine	increases expression	1
Antirheumatic Agents	increases expression	1

Cellosaurus cell lines

1 cell lines: 1 transformed cell line

First 10 cell lines (id-ordered, not curated):

Cellosaurus	Name	Category	Sex
CVCL_HD38	HEK293 eGFP-ZNF664	Transformed cell line	Female

Clinical trials (associated diseases)

0 trials via MONDO — disease-level, not drug-specific.